FBInvestor
Stocks / Aslan Pharmaceuticals Lt Adr
Institutional Ownership

Aslan Pharmaceuticals Lt Adr

CUSIP 04522R309COMASLNEURQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon